Skip to main content
logo
Takeda Pharmaceutical Company Limited (TYO:4502)
Japan flag Japan · Delayed Price · Currency is JPY
4,214.00
-5.00 (-0.12%)
Aug 5, 2025, 3:30 PM JST

PowerSchool Holdings Revenue

Takeda Pharmaceutical Company had revenue of 1.11T JPY in the quarter ending June 30, 2025, a decrease of -8.39%. This brings the company's revenue in the last twelve months to 4.48T, up 1.52% year-over-year. In the fiscal year ending March 31, 2025, Takeda Pharmaceutical Company had annual revenue of 4.58T with 7.45% growth.

Revenue (ttm)
4,480.25B
Revenue Growth
+1.52%
P/S Ratio
1.47
Revenue / Employee
94.41M
Employees
47,455
Market Cap
6,582.24B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20254,581.55B317.79B7.45%
Mar 31, 20244,263.76B236.28B5.87%
Mar 31, 20234,027.48B458.47B12.85%
Mar 31, 20223,569.01B371.19B11.61%
Mar 31, 20213,197.81B-93.38B-2.84%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chugai Pharmaceutical1,196.22B
Daiichi Sankyo Company1,924.68B
HOYA Corporation876.09B
Otsuka Holdings2,401.70B
Terumo1,036.17B
Astellas Pharma1,944.99B
Shionogi &440.50B
Olympus997.33B
Revenue Rankings

Takeda Pharmaceutical Company News

More News